Stock data
Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc. (ANRO) reported net income of -US$63.24M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$66.36M | -US$63.24M | — |
| 2024 | — | — | -US$68.61M | -US$61.43M | — |
| 2023 | — | — | -US$37.81M | -US$36.30M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$27.64M | — |
| 2026-03-31 | — | -US$26.24M | — |
| 2025-12-31 | — | -US$16.18M | — |
| 2025-09-30 | — | -US$14.18M | — |
| 2025-06-30 | — | -US$17.71M | — |
| 2025-03-31 | — | -US$15.17M | — |
| 2024-12-31 | — | -US$15.20M | — |
| 2024-09-30 | — | -US$16.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.